Results
|
61.
|
|
|
62.
|
Methotrexate plus or minus cetuximab as first-line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin combination treatment, a phase Ib-randomized phase II study Commence. [electronic resource] by
- Ham, Janneke C
- van Meerten, Esther
- Fiets, W Edward
- Beerepoot, Laurens V
- Jeurissen, Frank J F
- Slingerland, Marije
- Jonker, Marianne A
- Husson, Olga
- van der Graaf, Winette T A
- van Herpen, Carla M L
Producer: 20210621
In:
Head & neck vol. 42
Availability: No items available.
|
|
63.
|
|
|
64.
|
|
|
65.
|
Sunitinib does not attenuate contractile force following a period of ischemia in isolated human cardiac muscle. [electronic resource] by
- Thijs, Anna M J
- El Messaoudi, Saloua
- Vos, Johanna C M
- Wouterse, Alfons C
- Verweij, Vivienne
- van Swieten, Henry
- van Herpen, Carla M L
- van der Graaf, Winette T A
- Noyez, Luc
- Rongen, Gerard A
Producer: 20160621
In:
Targeted oncology vol. 10
Availability: No items available.
|
|
66.
|
|
|
67.
|
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma. [electronic resource] by
- Huijts, Charlotte M
- Werter, Inge M
- Lougheed, Sinéad M
- Goedegebuure, Ruben S
- van Herpen, Carla M
- Hamberg, Paul
- Tascilar, Metin
- Haanen, John B
- Verheul, Henk M
- de Gruijl, Tanja D
- van der Vliet, Hans J
Producer: 20190225
In:
Cancer immunology, immunotherapy : CII vol. 68
Availability: No items available.
|
|
68.
|
Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours. [electronic resource] by
- van Cruijsen, Hester
- Voest, Emile E
- Punt, Cornelis J A
- Hoekman, Klaas
- Witteveen, Petronella O
- Meijerink, Martijn R
- Puchalski, Thomas A
- Robertson, Jane
- Saunders, Owain
- Jürgensmeier, Juliane M
- van Herpen, Carla M L
- Giaccone, Giuseppe
Producer: 20100614
In:
European journal of cancer (Oxford, England : 1990) vol. 46
Availability: No items available.
|
|
69.
|
|
|
70.
|
|
|
71.
|
Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma. [electronic resource] by
- Stillebroer, Alexander B
- Boerman, Otto C
- Desar, Ingrid M E
- Boers-Sonderen, Marije J
- van Herpen, Carla M L
- Langenhuijsen, Johannes F
- Smith-Jones, Peter M
- Oosterwijk, Egbert
- Oyen, Wim J G
- Mulders, Peter F A
Producer: 20140331
In:
European urology vol. 64
Availability: No items available.
|
|
72.
|
Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters. [electronic resource] by
- Caetano-Pinto, Pedro
- Jamalpoor, Amer
- Ham, Janneke
- Goumenou, Anastasia
- Mommersteeg, Monique
- Pijnenburg, Dirk
- Ruijtenbeek, Rob
- Sanchez-Romero, Natalia
- van Zelst, Bertrand
- Heil, Sandra G
- Jansen, Jitske
- Wilmer, Martijn J
- van Herpen, Carla M L
- Masereeuw, Rosalinde
Producer: 20180319
In:
Molecular pharmaceutics vol. 14
Availability: No items available.
|
|
73.
|
|
|
74.
|
Long-term outcome and morbidity after treatment with accelerated radiotherapy and weekly cisplatin for locally advanced head-and-neck cancer: results of a multidisciplinary late morbidity clinic. [electronic resource] by
- Rütten, Heidi
- Pop, Lucas A M
- Janssens, Geert O R J
- Takes, Robert P
- Knuijt, Simone
- Rooijakkers, Antoinette F
- van den Berg, Manon
- Merkx, Matthias A
- van Herpen, Carla M L
- Kaanders, Johannes H A M
Producer: 20120106
In:
International journal of radiation oncology, biology, physics vol. 81
Availability: No items available.
|
|
75.
|
Olaparib tablet formulation: effect of food on the pharmacokinetics after oral dosing in patients with advanced solid tumours. [electronic resource] by
- Plummer, Ruth
- Swaisland, Helen
- Leunen, Karin
- van Herpen, Carla M L
- Jerusalem, Guy
- De Grève, Jacques
- Lolkema, Martijn P
- Soetekouw, Patricia
- Mau-Sørensen, Morten
- Nielsen, Dorte
- Spicer, James
- Fielding, Anitra
- So, Karen
- Bannister, Wendy
- Molife, L Rhoda
Producer: 20151217
In:
Cancer chemotherapy and pharmacology vol. 76
Availability: No items available.
|
|
76.
|
Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study. [electronic resource] by
- Mulder, Sasja F
- Bertens, Dirk
- Desar, Ingrid M E
- Vissers, Kris C P
- Mulders, Peter F A
- Punt, Cornelis J A
- van Spronsen, Dick-Johan
- Langenhuijsen, Johan F
- Kessels, Roy P C
- van Herpen, Carla M L
Producer: 20141106
In:
BMC cancer vol. 14
Availability: No items available.
|
|
77.
|
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 study. [electronic resource] by
- Urba, Susan
- van Herpen, Carla M L
- Sahoo, Tarini Prasad
- Shin, Dong M
- Licitra, Lisa
- Mezei, Klara
- Reuter, Christoph
- Hitt, Ricardo
- Russo, Francesca
- Chang, Shao-Chun
- Hossain, Anwar M
- Frimodt-Moller, Bente
- Koustenis, Andrew
- Hong, Ruey-Long
Producer: 20121126
In:
Cancer vol. 118
Availability: No items available.
|
|
78.
|
Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study). [electronic resource] by
- Driessen, Chantal M
- Ham, Janneke C
- Te Loo, Maroeska
- van Meerten, Esther
- van Lamoen, Maurits
- Hakobjan, Marina H
- Takes, Robert P
- van der Graaf, Winette T
- Kaanders, Johannes H
- Coenen, Marieke J H
- van Herpen, Carla M
Publication details: Cancers Apr 2019
In:
Cancers vol. 11
Availability: No items available.
|
|
79.
|
|
|
80.
|
|